MarketWatch
May 04

: Pfizer’s next play: A vaccine maker and pandemic ‘partner’ to governments

Pfizer Inc.’s COVID-19 vaccine is on track to generate a whopping $26 billion in sales this year, making it the drug maker’s top-selling drug and forging a new path into infectious diseases for the legacy drug maker.

Iratkozzon fel hírlevelünkre!

A legfrissebb gazdasági hírek, minden nap.